Para citar este trabalho use um dos padrões abaixo:
Lavendustin A, a natural product isolated from Streptomyces griseolavendus extracts, present a salicylic acid subunit bearing an amino group N,N-substituted with polyhydroxylated benzyl groups [1]. It is a potent inhibitor of Epidermal Growth Factor Receptor-Protein Tyrosine Kinase (EGFR-PTK), therefore an important target in the therapy against cancer [1]. Additionally, some Lavendustin A analogs have been also reported as tubulin polymerization inhibitors [2], which is an important molecular target against cancer and parasitic diseases [3,4]. Particularly, neglected diseases are a public health problem in Brazil, and new researches in this field are required aiming at the discovery of new and more efficient drugs. To the best of our knowledge, Lavendustine A and its synthetic analogs have been more widely reported as anticancer agents than antiparasitics [5-8]. In this sense, herein we aim the synthesis of novel triazolic-Lavendustin A analogs, their structural elucidations and biological evaluation against T. cruzi epimastigotes. The analogs were obtained from Cu(I)-mediated 1,3-dipolar cycloadditions between an intermediate with a terminal alkyne moiety and aromatic azides (click chemistry approach). The Lavendustin A subunit bearing an alkyne group was initially obtained reacting hydroxylated benzaldehydes with 5-aminosalicylic methyl ester, in a reductive amination reaction, and the resulting arylbenzylamine was alkylated with propargyl bromide. For the in silico study, comparative modeling using Bos Taurus tubulin will be performed, since the three-dimensional structure of T. cruzi tubulin is not available on structural databases [9,10]. After that, docking studies will be performed. In addition, chemogenomics approaches and calculations of ADMET properties will also be performed aiming at investigating putative off-targets and druglike properties. In our initial investigations, the triazolic-Lavendustin analogs were undoubtedly characterized by 1D and 2D NMR spectra analysis, their biological activities were initially evaluated against T. cruzi epimastigotes and in silico studies are in their initial stage. When triazolic-Lavendustine A analogs were biologically evaluated, the cytotoxicity assays against T. cruzi and primate epithelial cells (VERO cells) showed both IC50 values in the micromolar range. Although the analogs presented good bioactivity against T. cruzi, their cytotoxicity against primate cells may be a disadvantage. To overcome this problem, new analogs are being proposed and, in this approach, the hydroxyl groups in the benzyl subunit now appear methoxylated. This handling was imagined based on results reported in the literature, in which the O-methylated analogs were not active as EGFR-PTK inhibitors, but maintain their inhibition in the tubulin polymerization process [11,12]. As T. cruzi does not have EGFR associated PTKs, we hope that the suppression of this target does not alter antiparasitic activity but decreases the undesired cytotoxic action towards primate cells.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo